Literature DB >> 28126437

Novel salicylanilides from 4,5-dihalogenated salicylic acids: Synthesis, antimicrobial activity and cytotoxicity.

Georgios Paraskevopoulos1, Sara Monteiro2, Rudolf Vosátka3, Martin Krátký3, Lucie Navrátilová4, František Trejtnar4, Jiřina Stolaříková5, Jarmila Vinšová6.   

Abstract

Salicylanilides have proved their activity against tuberculosis (TB). One weak electron-withdrawing substituent is favored at the salicylic part, specially Cl or Br atoms at positions 4 or 5. On the other hand, the antimycobacterial activity of salicylanilides is negatively affected when a strong electron-withdrawing substituent (NO2) is present at the same positions. Herein we describe the synthesis and characterization of novel salicylanilides possessing two weak electron-withdrawing groups (halogen atoms) at their salicylic part and compare their antitubercular activity with their monohalogenated analogues. All dihalogenated derivatives proved to possess antitubercular activity at a very narrow micromolar range (MIC=1-4μM), similar with their most active monohalogenated analogues. More importantly, the most active final molecules were further screened against multidrug resistant strains and found to inhibit their growth at the range of 0.5-4μM.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cytotoxicity; Double halogenation; In vitro antimycobacterial activity; Salicylanilides; Tuberculosis

Mesh:

Substances:

Year:  2017        PMID: 28126437     DOI: 10.1016/j.bmc.2017.01.016

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  2-Hydroxy-N-phenylbenzamides and Their Esters Inhibit Acetylcholinesterase and Butyrylcholinesterase.

Authors:  Martin Krátký; Šárka Štěpánková; Neto-Honorius Houngbedji; Rudolf Vosátka; Katarína Vorčáková; Jarmila Vinšová
Journal:  Biomolecules       Date:  2019-11-05

2.  Novel Chloro-Substituted Salicylanilide Derivatives and Their β-Cyclodextrin Complexes: Synthesis, Characterization, and Antibacterial Activity.

Authors:  Ioana Maria Carmen Ienașcu; Adina Căta; Mariana Nela Ştefănuț; Iuliana Popescu; Gerlinde Rusu; Paula Sfîrloagă; Daniel Ursu; Cristina Moşoarcă; Anamaria Dabici; Corina Danciu; Delia Muntean; Raluca Pop
Journal:  Biomedicines       Date:  2022-07-19

3.  Reversible Small Molecule Inhibitors of MAO A and MAO B with Anilide Motifs.

Authors:  Jens Hagenow; Stefanie Hagenow; Kathrin Grau; Mohammad Khanfar; Lena Hefke; Ewgenij Proschak; Holger Stark
Journal:  Drug Des Devel Ther       Date:  2020-01-28       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.